Position in GERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$381,331
-$218,557 QoQ
Shares Held
255,927
-41.6% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,577 | $20,313,062 | |
| 2 | CYTK |
Cytokinetics Inc
|
125,090 | $10,656,417 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
157,710 | $8,959,505 | |
| 4 | ARGX |
Argenx SE
|
7,697 | $7,141,045 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
83,470 | $6,808,647 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
99,530 | $5,468,178 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,480 | $4,659,944 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
36,670 | $4,292,956 |
All Filings in GERN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $381,331 | 255,927 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $599,888 | 437,875 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $1,481,635 | 418,541 | Shares | Sole | 2025-02-14 | |
| 2022-12-31 | $4,840 | 2,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||